Securian Asset Management Inc. Takes Position in Bath & Body Works, Inc. (NYSE:BBWI)

Securian Asset Management Inc. bought a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 16,449 shares of the company's stock, valued at approximately $499,000.

A number of other large investors have also modified their holdings of BBWI. Golden State Wealth Management LLC raised its holdings in Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after acquiring an additional 642 shares in the last quarter. UMB Bank n.a. increased its holdings in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Bath & Body Works by 109.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock worth $63,000 after buying an additional 852 shares during the last quarter. Ancora Advisors LLC acquired a new position in Bath & Body Works during the 4th quarter worth $67,000. Finally, TD Private Client Wealth LLC boosted its holdings in shares of Bath & Body Works by 34.9% in the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock valued at $89,000 after buying an additional 593 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

BBWI opened at $31.74 on Friday. Bath & Body Works, Inc. has a 1-year low of $24.94 and a 1-year high of $41.87. The business has a 50 day moving average price of $30.15 and a two-hundred day moving average price of $32.35. The company has a market capitalization of $6.72 billion, a price-to-earnings ratio of 8.46, a price-to-earnings-growth ratio of 1.03 and a beta of 1.72.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same quarter last year, the business posted $0.38 earnings per share. Bath & Body Works's revenue for the quarter was up 2.9% compared to the same quarter last year. Equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's payout ratio is currently 21.33%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of research reports. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. UBS Group raised their price objective on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a report on Tuesday, May 20th. Raymond James Financial cut their price target on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th. The Goldman Sachs Group lowered their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Finally, Barclays reduced their price objective on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research report on Friday, May 30th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.